Advertisement
Screener

UTAH MEDICAL PRODUCTS, INC. (UTMD) Graph

UTMD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $8.53M; Cost of revenue $3.77M; Research and development $154.00K; Selling, general and administrative $1.96M.
  • 2026-03-31: Revenue $8.72M; Cost of revenue $3.44M; Research and development $154.00K; Selling, general and administrative $2.56M.
  • 2025-12-31: Revenue $9.04M; Cost of revenue $3.78M*; Research and development $212.00K*; Selling, general and administrative (m).
  • 2025-09-30: Revenue $9.81M; Cost of revenue $4.21M; Research and development $167.00K; Selling, general and administrative $2.83M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

UTMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Blood Pressure MonitoringAnd Accessories$1.26MGynecologyElectrosurgery Urology$4.28MNeonatal$1.92MObstetrics$1.07MRevenue$8.53MCost of revenue$3.77MGross profit$4.76MOperating expenses$2.11MOperating income$2.65MOther income, net$637.00KResearch & development$154.00KSelling, general& administrative$1.96MPre-tax income$3.29MIncome tax$600.00KNet income$2.69M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

UTMD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Domestic Us$5.17MOutside Us$3.36MRevenue$8.53MCost of revenue$3.77MGross profit$4.76MOperating expenses$2.11MOperating income$2.65MOther income, net$637.00KResearch & development$154.00KSelling, general& administrative$1.96MPre-tax income$3.29MIncome tax$600.00KNet income$2.69M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome tax
2026-06-30$8.53M$3.77M$154.00K$1.96M$2.11M$600.00K
2026-03-31$8.72M$3.44M$154.00K$2.56M$2.72M$578.00K
2025-12-31$9.04M$3.78M*$212.00K*(m)(m)$540.00K*
2025-09-30$9.81M$4.21M$167.00K$2.83M$2.99M$678.00K
2025-06-30$9.95M$4.36M$135.00K$2.26M$2.40M$788.00K
2025-03-31$9.71M$4.17M$154.00K$2.23M$2.38M$817.00K
2024-12-31$9.16M(m)(m)(m)(m)(m)
2024-09-30$10.01M$4.20M$172.00K$2.29M$2.46M$616.00K
2024-06-30$10.40M$4.15M$255.00K$2.56M$2.81M$758.00K
2024-03-31$11.34M$4.57M$266.00K$2.62M$2.88M$842.00K
2023-12-31$12.33M(m)(m)(m)(m)(m)
2023-09-30$12.51M$5.15M$138.00K$3.25M$3.39M$846.00K
2023-06-30$12.87M$5.13M$133.00K$3.18M$3.31M$972.00K
2023-03-31$12.52M$4.68M$144.00K$3.26M$3.40M$905.00K
2022-12-31$13.57M(m)(m)(m)(m)(m)
2022-09-30$12.96M$4.77M$112.00K$2.93M$3.04M$1.06M
2022-06-30$13.43M$5.28M$135.00K$2.96M$3.09M$1.10M
2022-03-31$12.32M$4.79M$123.00K$2.89M$3.01M$996.00K
2021-12-31$12.91M(m)(m)(m)(m)(m)
2021-09-30$12.57M$4.50M$127.00K$2.85M$2.98M$951.00K
2021-06-30$12.60M$4.82M$128.00K$2.89M$3.02M$1.40M
2021-03-31$10.96M$4.02M$130.00K$2.93M$3.06M$874.00K
2020-12-31$12.01M(m)(m)(m)(m)(m)
2020-09-30$10.48M$3.98M$125.00K$2.79M$2.91M$655.00K
2020-06-30$8.79M$3.84M$116.00K$2.86M$2.97M$664.00K
2020-03-31$10.90M$4.07M$135.00K$2.84M$2.97M$848.00K
2019-12-31$11.83M(m)(m)(m)(m)(m)
2019-09-30$12.49M$5.12M$130.00K$2.88M$3.01M$742.00K
2019-06-30$11.85M$4.35M$113.00K$2.91M$3.02M$1.04M
2019-03-31$10.73M$3.96M$115.00K$2.56M$2.67M$998.00K
2018-12-31$9.76M(m)(m)(m)(m)(m)
2018-09-30$10.39M$4.10M$108.00K$1.78M$1.89M-$2.28M
2018-06-30$10.96M$3.98M$117.00K$1.81M$1.93M$1.25M
2018-03-31$10.89M$3.96M$113.00K$1.84M$1.95M$916.00K
2017-12-31$10.20M(m)(m)(m)(m)(m)
2017-09-30$10.13M$3.63M$103.00K$1.71M$1.82M$1.07M
2017-06-30$10.83M(m)$119.00K$1.74M$1.86M$1.19M
2017-03-31$10.26M(m)$118.00K$1.69M$1.81M$1.22M
2016-09-30$9.65M(m)$135.00K$1.70M$1.84M$1.04M
2016-06-30$10.49M(m)$119.00K$1.82M$1.94M$1.12M
2016-03-31$10.30M(m)$110.00K$1.80M$1.91M$1.20M
2015-09-30$9.95M(m)$110.00K$1.97M$2.08M$1.08M
2015-06-30$10.40M(m)$140.00K$1.99M$2.13M$1.01M
2015-03-31$10.23M(m)$156.00K$2.08M$2.23M$1.00M
2014-09-30$10.72M(m)$115.00K$2.08M$2.19M$1.07M
2014-06-30$10.49M(m)$115.00K$2.17M$2.29M$1.10M
2014-03-31$9.83M(m)$123.00K$2.08M$2.21M$1.06M
2013-09-30$10.03M(m)$126.00K$2.16M$2.28M$1.01M
2013-06-30$10.00M(m)$120.00K$2.21M$2.33M$994.00K
2013-03-31$10.37M(m)$123.00K$2.27M$2.39M$1.05M
2012-09-30$10.49M(m)$140.00K$2.38M$2.52M$1.13M
2012-06-30$10.03M(m)$147.00K$2.37M$2.52M$1.03M
2012-03-31$11.21M(m)$146.00K$2.48M$2.62M$1.15M
2011-09-30$10.78M(m)$138.00K$2.84M$2.98M$1.04M
2011-06-30$10.38M(m)$148.00K$2.88M$3.03M$970.00K
2011-03-31$6.79M(m)$101.00K$1.45M$1.55M$806.00K
2010-09-30$6.20M(m)$101.00K$977.00K$1.08M$777.00K
2010-06-30$6.28M(m)$95.00K$977.00K$1.07M$744.00K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome tax
2026-06-30$17.25M$7.21M$308.00K$4.52M$4.83M$1.18M
2025-06-30$19.66M$8.53M$289.00K$4.50M$4.78M$1.60M
2024-06-30$21.74M$8.72M$521.00K$5.18M$5.70M$1.60M
2023-06-30$25.39M$9.80M$277.00K$6.44M$6.72M$1.88M
2022-06-30$25.75M$10.07M$258.00K$5.85M$6.10M$2.09M
2021-06-30$23.57M$8.84M$259.00K$5.82M$6.08M$2.27M
2020-06-30$19.69M$7.90M$250.00K$5.70M$5.95M$1.51M
2019-06-30$22.58M$8.31M$228.00K$5.46M$5.69M$2.04M
2018-06-30$21.85M$7.95M$230.00K$3.65M$3.88M$2.17M
2017-06-30$21.09M(m)$238.00K$3.43M$3.67M$2.40M
2016-06-30$20.79M(m)$229.00K$3.62M$3.85M$2.32M
2015-06-30$20.63M(m)$296.00K$4.07M$4.37M$2.01M
2014-06-30$20.32M(m)$238.00K$4.26M$4.49M$2.16M
2013-06-30$20.38M(m)$243.00K$4.48M$4.72M$2.05M
2012-06-30$21.23M(m)$293.00K$4.85M$5.14M$2.18M
2011-06-30$17.17M(m)$248.00K$4.33M$4.58M$1.78M
2010-06-30$12.71M(m)$190.00K$1.92M$2.11M$1.52M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome tax
2025-09-30$29.48M$12.74M$456.00K$7.32M$7.78M$2.28M
2024-09-30$31.75M$12.93M$692.00K$7.46M$8.16M$2.22M
2023-09-30$37.89M$14.95M$414.00K$9.69M$10.11M$2.72M
2022-09-30$38.71M$14.84M$370.00K$8.78M$9.15M$3.15M
2021-09-30$36.14M$13.34M$385.00K$8.67M$9.05M$3.22M
2020-09-30$30.17M$11.88M$375.00K$8.48M$8.86M$2.17M
2019-09-30$35.07M$13.42M$357.00K$8.34M$8.70M$2.78M
2018-09-30$32.24M$12.04M$338.00K$5.43M$5.77M-$116.00K
2017-09-30$31.21M$11.29M$341.00K$5.15M$5.49M$3.48M
2016-09-30$30.45M(m)$364.00K$5.32M$5.68M$3.36M
2015-09-30$30.57M(m)$406.00K$6.04M$6.45M$3.09M
2014-09-30$31.04M(m)$352.00K$6.34M$6.69M$3.23M
2013-09-30$30.41M(m)$369.00K$6.64M$7.01M$3.05M
2012-09-30$31.72M(m)$433.00K$7.23M$7.66M$3.31M
2011-09-30$27.95M(m)$386.00K$7.17M$7.56M$2.81M
2010-09-30$18.91M(m)$292.00K$2.89M$3.18M$2.30M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentIncome tax
2025-12-31$38.52M$16.52M$668.00K$2.82M
2024-12-31$40.90M$16.76M$813.00K$2.93M
2023-12-31$50.22M$20.19M$560.00K$3.45M
2022-12-31$52.28M$20.09M$493.00K$4.19M
2021-12-31$49.05M$18.14M$526.00K$4.27M
2020-12-31$42.18M$16.63M$486.00K$3.04M
2019-12-31$46.90M$17.44M$483.00K$3.16M
2018-12-31$42.00M$15.69M$454.00K$904.00K
2017-12-31$41.41M$15.02M$447.00K$10.58M
2016-12-31$39.30M$15.61M$475.00K$4.29M
2015-12-31$40.16M(m)$522.00K$3.70M
2014-12-31$41.28M(m)$460.00K$4.43M
2013-12-31$40.49M(m)$491.00K$3.07M
2012-12-31$41.55M(m)$563.00K$4.37M
2011-12-31$37.86M(m)-$518.00K$3.67M
2010-12-31$25.12M(m)$397.00K$3.03M
2009-12-31$25.92M(m)$361.00K$3.32M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRO DEX INC (PDEX)United States$0.234B13.64
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32